HAEMONETICS CORP MASS's ticker is and the CUSIP is 405024AB6.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $444,975 | -48.2% | 510,000 | -49.5% | 0.23% | -45.3% |
Q2 2023 | $859,406 | +0.3% | 1,010,000 | 0.0% | 0.42% | +21.6% |
Q1 2023 | $856,968 | +2.7% | 1,010,000 | 0.0% | 0.34% | +3.3% |
Q4 2022 | $834,563 | +3.3% | 1,010,000 | 0.0% | 0.33% | -3.5% |
Q3 2022 | $808,000 | +2.5% | 1,010,000 | +1.0% | 0.34% | +8.2% |
Q2 2022 | $788,000 | – | 1,000,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Context Capital Management, LLC | 17,558 | $15,028 | 1.36% |
OSTERWEIS CAPITAL MANAGEMENT INC | 18,000,000 | $15,406,154 | 1.02% |
ADVENT CAPITAL MANAGEMENT /DE/ | 53,348,000 | $45,660,417 | 0.88% |
DeepCurrents Investment Group LLC | 24,371,000 | $20,841,796 | 0.82% |
MACKAY SHIELDS LLC | 29,499,000 | $25,204,736 | 0.70% |
SSI INVESTMENT MANAGEMENT LLC | 11,208,000 | $9,536,859 | 0.67% |
Aequim Alternative Investments LP | 20,500,000 | $17,545,898 | 0.66% |
Quaero Capital S.A. | 900,000 | $769,635 | 0.59% |
READYSTATE ASSET MANAGEMENT LP | 8,000,000 | $6,847,180 | 0.52% |
Empyrean Capital Partners, LP | 12,000,000 | $10,215,000 | 0.46% |